Yunfei Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Yunfei Yu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Luchen Yang
Department of Urology West China Hospital Sichuan University Chengdu China
1 shared publicationPan Song
Department of Urology West China Hospital Sichuan University Chengdu China
1 shared publication- Qiang Dong
Department of Urology, West China Hospital, Sichuan University, Chengdu, China
1 shared publication Shengzhuo Liu
Department of Urology West China Hospital Sichuan University Chengdu China
1 shared publication- Xiaoyang Liu
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China
1 shared publication Xin Yan
Department of Urology West China Hospital Sichuan University Chengdu China
1 shared publication
Latest Publications
- Open Access
Roles of reactive oxygen species in inflammation and cancer
Reactive oxygen species (ROS) constitute a spectrum of oxygenic metabolites crucial in modulating pathological organism functions. Disruptions in ROS equilibrium span various diseases, and current insights suggest a dual role for ROS in tumorigenesis and the immune response within cancer. This review rigorously examines ROS production and its role in normal cells, elucidating the subsequent regulatory network in inflammation and cancer. Comprehensive synthesis details the documented impacts of ROS on diverse immune cells. Exploring the intricate relationship between ROS and cancer immunity, we highlight its influence on existing immunotherapies, including immune checkpoint blockade, chimeric antigen receptors, and cancer vaccines. Additionally, we underscore the promising prospects of utilizing ROS and targeting ROS modulators as novel immunotherapeutic interventions for cancer. This review discusses the complex interplay between ROS, inflammation, and tumorigenesis, emphasizing the multifaceted functions of ROS in both physiological and pathological conditions. It also underscores the potential implications of ROS in cancer immunotherapy and suggests future research directions, including the development of targeted therapies and precision oncology approaches. In summary, this review emphasizes the significance of understanding ROS‐mediated mechanisms for advancing cancer therapy and developing personalized treatments.
Open AccessRoles of reactive oxygen species in inflammation and cancer
Reactive oxygen species (ROS) constitute a spectrum of oxygenic metabolites crucial in modulating pathological organism functions. Disruptions in ROS equilibrium span various diseases, and current insights suggest a dual role for ROS in tumorigenesis and the immune response within cancer. This review rigorously examines ROS production and its role in normal cells, elucidating the subsequent regulatory network in inflammation and cancer. Comprehensive synthesis details the documented impacts of ROS on diverse immune cells. Exploring the intricate relationship between ROS and cancer immunity, we highlight its influence on existing immunotherapies, including immune checkpoint blockade, chimeric antigen receptors, and cancer vaccines. Additionally, we underscore the promising prospects of utilizing ROS and targeting ROS modulators as novel immunotherapeutic interventions for cancer. This review discusses the complex interplay between ROS, inflammation, and tumorigenesis, emphasizing the multifaceted functions of ROS in both physiological and pathological conditions. It also underscores the potential implications of ROS in cancer immunotherapy and suggests future research directions, including the development of targeted therapies and precision oncology approaches. In summary, this review emphasizes the significance of understanding ROS‐mediated mechanisms for advancing cancer therapy and developing personalized treatments.